Page 50 - Read Online
P. 50

Page 144  Shad. J Transl Genet Genom 2023;7:141-65    https://dx.doi.org/10.20517/jtgg.2023.11



 Table 1. Significant genetic predictors of clozapine-induced agranulocytosis

                                             Controls
 CIA cases with   CIA cases without   Controls with
 Reference  Ethnicity  Haplotype             without     Specificity Sensitivity OR    P-value
 haplotype  haplotype    haplotype
                                             haplotype
 Lieberman et al.,   Mainly Jewish (22/31)  HLA-B38   5   0   4   13   100%   55%   16.25  0.005
 [39]
 1990  HLAB38-DR4-DQw3  5  0  2              15          100%        71%         37.5 0.008
 [40]
 Corzo et al., 1995  Jewish   HSP-70 9.0-A  16  8  10  44  81%       62%         8.8   0.0001
 Non-Jewish  HSP-70 9.0-A  19  21  6         26          81%         47%         3.92 0.01
 [41]
 Yunis et al., 1995  Ashkenazi Jewish  HLA-B38   14   1   7   25   96%   67%     50.0. < 0.0001
 HLA-DR4   14   1        12                  20          95%         54%         23.3
 HLA-B38, DR4, DQw3  13  2  6                26          93%         68%         28.2 0.0004
                                                                                      < 0.0001


 HLA-DRB1*0402   11   13   6                 48          79%         46%         5.7   0.002
 HLA-DQB1*0302   11   13   8                 46          78%         58%         4.9   0.008
 HLA-DQA1*0301   0   24   18                 36          60%         0.0%        12.0  0.008
 HLA-DRB1*11  0  24      13                  41          63%         0.0%        7.6   0.007
 HLA-DRB4*0101   10  14  6                   48          11%         42%         5.7   0.005
 HLA_DQB1*0302
 HLA-DQA1*0301
 Non-Jewish  -HLA-DR2   17   8   5           24          75%         62%         4.5   0.01
 -HLA-DR2, DQw1   14   11   4                15          58%         78%         4.8   0.03
 -HLA-B7, DR2, DQw1  6  19  0                19          50%         100%        6.0   0.03
 [42]
 Turbay et al., 1997  Non-Jewish  HSP-70 9.0-A  19  21  6  26  81%   47%         3.92 0.01
 Non-Jewish European  HLA-DQA1*0102   14   26   4   28   52%         78%         3.77  0.03
 TNFb4   29   13         6                   24          65%         83%         8.92  0.0005
 TNFb5  8  34            22                  8           19%         27%         0.08 0.0005
 [43]
 Amar et al., 1998  Jewish & Non-Jewish  HLA-DQB1*0201  5  5  7  6  55%  42%     0.86 0.03
 Valevski et al.,   Israeli Jewish   HLA-B38  5  5  7  50  91%       42%         10.01 0.04
 [44]
 1998
 Ostrousky et al.,   Jewish  NQ02 372 T>c   14   4   14   40   50    78          3.5   0.04
 [45]
 2003  NQ 02 202 G>A  17  1  54              26          33          94          8.2   0.05
 Lahdelma et al.,   Finnish  HLA-A1, HLA-A28, HLA-  3   23   11   8   26%   21%   0.95  0.0013
 [46]
 2001  B16  8   18       1                   18          50%         89%         8     0.027
 6  16                   2                   17          51%         75%         3.2   0.027
 Dettling et al.,   German Caucasians - non-  HLA-Cw*7   20   11   30   47   81%   40%   2.85  0.02
 [47]
 2001  Jewish   HLA-DPB*0401   23   8   40   33          80%         36%         2.37  0.03
 HLA-DQB*0502   5   26   1                   76          74%         83%         14.6  0.04
 HLA-DRB1*0101   3   28   20                 57          74%         9%          0.30  0.03
 HLA-DRB3*0202  14  17   21                  56          77%         40%         0.45 0.01
 Dettling et al.,   German Caucasians - non-  HLA-DRB5*0201   5   37   0   0   0%   100%   0.13  0.005
 Jewish   HLA-Cw7  29  13  33                42          76%         47%         2.84 0.035
   45   46   47   48   49   50   51   52   53   54   55